Search

everythinglearnresearchcommunity

for

Search:↓

The document concludes that new treatments are needed to better manage acne and reduce side effects related to current therapies.

Hormonal therapies might help treat hidradenitis suppurativa, but treatment is complex and personalized.

Transgender women can develop feminine traits and improve their quality of life through hormone therapy and surgery, but results vary and access to surgery can be limited.

Hormonal contraceptives can help treat acne by affecting sebum production and androgen levels.

Estrogen increases blood vessel growth factor production, while testosterone blocks this increase.

The conclusion is that proper evaluation and treatment of hair loss in midlife women is important, considering the emotional impact and potential for various treatments.

Obstetrician/gynecologists can diagnose and manage female hair loss with careful history taking and examination.

Irregular menstrual cycles in exercising women may be linked to energy deficiency or hormonal imbalances, requiring careful diagnosis for proper treatment.

The document concludes that changes in eyelashes and eyelid skin can indicate various local and systemic diseases.

The document concludes that early diagnosis is key for treating common baldness in women, but reassurance is often the best approach as hair thinning can be a normal part of aging.

The conclusion is that hair loss in women is caused by a mix of hormonal, environmental, and genetic factors, and treatments should target these various causes.

Skin problems can indicate different diseases inside the body.

Hormonal intrauterine devices (IUDs) may cause or worsen skin conditions influenced by androgens.

New and existing treatments for hair loss show promise, with some being more effective for men and others for women.

PCOS involves hormonal and metabolic issues, increasing risks for diabetes and heart disease, and requires lifestyle changes and medication for management.

Telogen effluvium is a common hair loss condition that can be managed with proper treatment and addressing underlying issues.

Elderly patients with CCCA were all African American with low vitamin D, but no iron or zinc deficiencies, and no hormonal imbalances compared to younger patients.

Finasteride may cause gum side effects in some patients.

Early-onset baldness is linked to genetics, lifestyle, and can indicate higher risk for heart and metabolic diseases, and affects mental health.

Some breast cancer treatments caused long-term hair loss in women, similar to a condition called alopecia areata.

A woman had temporary hair loss due to stress from a spinal cord injury.

Hormonal therapies, especially antiandrogens, can help manage Hidradenitis Suppurativa.

Cyproterone and finasteride reduced hypersexuality but caused serious side effects.

Acne affects most teenagers and can continue into adulthood, with various treatments available that show improvement but have concerns like antibiotic resistance and side effects.

Electrolysis is effective for permanent hair removal, but technique is key to avoid scarring, and sometimes hormonal treatment is needed for women with hirsutism.

The conclusion is that early diagnosis and a multi-system treatment approach are crucial for managing PCOS and its associated health risks.

The conclusion is that managing androgen excess requires long-term treatment, including hormonal contraceptives and androgen blockers, with follow-up after six months.

Environmental factors, hormones, nutrition, and stress all significantly affect skin health and aging.

PCOS is a common hormonal disorder in women, treated with lifestyle changes and medications like hormonal contraceptives and metformin.

People often struggle to consistently use contraceptives and other medications, and long-acting options might be better for those who want to avoid daily doses.